Interdepedence between cytokines and antioxidants in lymphocytes of patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005
Montelukast reduces Th2 type cytokines in induced sputum in mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007
Establishing the effects of chronic exposure to IL-9 alone and in combination with IL-13 on the differentiation of asthmatic and non-asthmatic paediatric bronchial epithelial cells Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions Source: Eur Respir J 2003; 21: 799-803 Year: 2003
Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo Source: Eur Respir J 2003; 21: 994-999 Year: 2003
Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Source: Eur Respir J 2001; 17: 499-506 Year: 2001
IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES) Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002